| Literature DB >> 34437584 |
Stephen Osei-Wusu1,2, Isaac Darko Otchere1,2, Portia Morgan1,2, Abdul Basit Musah1, Ishaque Mintah Siam1, Diana Asandem1,2, Theophilus Afum1, Prince Asare1,2, Adwoa Asante-Poku1, Kwadwo Asamoah Kusi1,2, Sebastien Gagneux3,4, Dorothy Yeboah-Manu1,2.
Abstract
Findings from previous comparative genomics studies of the Mycobacterium tuberculosis complex (MTBC) suggest genomic variation among the genotypes may have phenotypic implications. We investigated the diversity in the phenotypic profiles of the main prevalent MTBC genotypes in West Africa. Thirty-six whole genome sequenced drug susceptible MTBC isolates belonging to lineages 4, 5 and 6 were included in this study. The isolates were phenotypically characterized for urease activity, tween hydrolysis, Thiophen-2-Carboxylic Acid Hydrazide (TCH) susceptibility, nitric oxide production, and growth rate in both liquid (7H9) and solid media (7H11 and Löwenstein-Jensen (L-J)). Lineage 4 isolates showed the highest growth rate in both liquid (p = 0.0003) and on solid (L-J) media supplemented with glycerol (p<0.001) or pyruvate (p = 0.005). L6 isolates optimally utilized pyruvate compared to glycerol (p<0.001), whereas L5 isolates grew similarly on both media (p = 0.05). Lineage 4 isolates showed the lowest average time to positivity (TTP) (p = 0.01; Average TTP: L4 = 15days, L5 = 16.7days, L6 = 29.7days) and the highest logCFU/mL (p = 0.04; average logCFU/mL L4 = 5.9, L5 = 5.0, L6 = 4.4) on 7H11 supplemented with glycerol, but there was no significant difference in growth on 7H11 supplemented with pyruvate (p = 0.23). The highest release of nitrite was recorded for L5 isolates, followed by L4 and L6 isolates. However, the reverse was observed in the urease activity for the lineages. All isolates tested were resistant to TCH except for one L6 isolate. Comparative genomic analyses revealed several mutations that might explain the diverse phenotypic profiles of these isolates. Our findings showed significant phenotypic diversity among the MTBC lineages used for this study.Entities:
Mesh:
Year: 2021 PMID: 34437584 PMCID: PMC8389432 DOI: 10.1371/journal.pone.0255433
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Mycobacterial isolates (lineages/sub-lineages) used for each experiment.
| Growth on 7H11(TTP&CFU) | Growth on L-J | Growth in Liquid medium | Nitrite | Nitrate | Urease test | Tween hydrolysis | TCH | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lineage(L) | Sub-lineage (s-L) | s-L | L | s-L | L | s-L | L | s-L | L | s-L | L | s-L | L | s-L | L | s-L | L |
|
| Cameroon | 1 | 2 | 3 | 5 | 2 | 6 | 2 | 6 | 5 | 9 | 4 | 8 | 2 | 4 | 5 | 10 |
| Ghana | 1 | 2 | 4 | 4 | 4 | 4 | 2 | 5 | |||||||||
|
| L5.C1 | 1 | 5 | 2 | 5 | 1 | 8 | 2 | 6 | 2 | 9 | 2 | 9 | 2 | 10 | 2 | 10 |
| L5.C2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | |||||||||
| L5.C3 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||||||
| L5.C4 | 1 | 1 | 1 | 2 | 2 | 2 | |||||||||||
| L5.C5 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | ||||||||||
|
| L6.C1 | 1 | 3 | 2 | 5 | 1 | 6 | 1 | 4 | 3 | 7 | 2 | 8 | 2 | 6 | 3 | 10 |
| L6.C2 | 1 | 2 | 3 | 2 | 3 | 4 | 2 | 4 | |||||||||
| L6.C3 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 3 | |||||||||
|
|
|
|
|
|
|
|
|
| |||||||||
The table summarizes the total numbers of mycobacterial isolates used for each experiment. It displays the number of each lineage as well as sub-lineage.
s-L = sub-lineage, L = lineage.
Fig 1Utilization of different carbon sources on Löwenstein-Jensen media slants.
Growth was compared as degree of positivity (WHO standard for grading Mtb growth on L-J) on both glycerol and pyruvate supplemented media slants. Two-way analysis of variance (ANOVA) considering Time as a factor showed significant difference between the 3 lineages on glycerol (p<0.001) and on pyruvate (p = 0.005) supplemented media.
Fig 2Time to positivity (TTP) on 7H11 media.
The average time to positivity was measured in terms of the number of days it took for the first colonies to appear for CFU determination and plotted against the various media compositions.
Fig 3Growth rate on 7H11 media.
The average logCFU/ml was plotted against the different supplemented media.
Fig 4Growth rate in liquid medium.
Optical density at 600nm was measured at the data points (days) and indicated by the symbols. The data points are the averages of individual strains belonging to the 3 different lineages.
Mutational analysis of genes that may be associated with growth rate.
| Isolate | Gene name | Mutation | Description |
|---|---|---|---|
| L6.C3, L5.C2 & L5.C1 |
| R16P, Y98H & V75I | Putative cell division ATP-binding protein FTSE (septation component-transport ATP-binding protein ABC transporter) |
| L6.2 (one isolate:1283) |
| T125I | Possible Hemoglobine-related protein HMP. Possible ketosteroid-9-alpha-hydroxylase. |
| L5 only |
| V251L | Transmembrane Serine/Threonine-protein kinase B PKNB (Protein Kinase B) (STPK B) |
| Maf only |
| R3L | Phosphoserine/Threonine Phosphatase PSTP |
| Maf only |
| S455A | Phosphoserine/Threonine Phosphatase PSTP |
| L5.3 (one isolate: 2196) |
| S475R | Phosphoserine/Threonine Phosphatase PSTP |
| All except H37Rv |
| R126Q | Probable resuscitation-promoting factor RPFE |
| L5.C1 only |
| A87V | Probable resuscitation-promoting factor RPFE |
| L6 only |
| D43A | Possible extragenic suppressor protein SUHB |
| L5 only |
| A196G | Possible extragenic suppressor protein SUHB |
| L5 only |
| E71stop | Transcriptional regulatory protein WHIB-like WHIB3 |
Fig 5Comparison of nitrite concentration.
The individual isolates are represented by the black points in the boxplot.
Genomic analysis for genes that may be involved in nitric oxide.
| Isolate | Gene name | Mutation | Description |
|---|---|---|---|
| L5 only |
| S435R | Probable Respiratory Nitrate Reductase (Alpha Chain) NARG |
| L6.C1 |
| E967G | Probable Respiratory Nitrate Reductase (Alpha Chain) NARG |
| Ghana (3742) |
| Y389C | Probable Nitrite Extrusion Protein 1 NARK1 (Nitrite Facilitator 1) |
| L5.C3 (1186) |
| A226E | Probable Integral Membrane Nitrite Extrusion Protein NARK3 (Nitrite Facilitator) |
| Ghana & Cameroon |
| V409I | Probable Integral Membrane Nitrite Extrusion Protein NARK3 (Nitrite Facilitator) |
| L6 only |
| P18L | Possible Nitrate/Nitrite Response Transcriptional Regulatory Protein NARL |
| Cameroon (1175) |
| R49Q | Probable Nitrate Reductase NARX |
| Maf only |
| D77G | Probable Nitrate Reductase NARX |
| L6.C1 |
| A355T | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| L6.C3 (2150) |
| H382Q | Probable Transcriptional Regulatory Protein (Probably LUXR-Family) |
| Cameroon (1030) |
| R519H | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| L5.C3 (1186) |
| E603G | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| L6.C1 |
| V647G | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| All except H37Rv |
| P866A | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| L5 only |
| Q286R | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| L6.C2 (1283) |
| Y300H | Probable Transcriptional Regulatory Protein (Probably LUXR-family) |
| L5.C2 |
| D265A | Probable Reductase |
| Cameroon (1175) |
| W214stop | Probable Conserved Integral Membrane Protein |
Fig 6Comparison of nitrate concentration.
The individual isolates are represented by the black points in the boxplot.
Fig 7Comparison of urease activity of the three different lineages.
A negative control depicted by the blue line was only urea broth. H37Rv was included in the experimental set-up as a positive control (black line).
Genomic analysis for urease activity test.
| Lineage | Gene | Mutation | Gene function |
|---|---|---|---|
| L5.C2 |
| G98D & Y169C | Transcriptional Regulatory Protein |
| L5.C1 |
| T125I | Probable Phospho-Sugar Mutase/Mrsa Protein Homolog |
Fig 8Tween hydrolysis test.
A negative control depicted by the blue line had only the Tween hydrolysis reagent. Mycobacterium aurum represented by the purple line was included in the experimental set-up as a positive control.
Thiophen-2-carboxylic acid hydrazide (TCH) susceptibility profile.
| Isolate ID | Sub-lineage | Lineage | TCH results | Gene | Mutation | Isolate ID | Sub-lineage | Lineage | TCH results | Gene | Mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|
| H37Rv | R | - | - | 1283 | L6.2 | L6 | R | - | - | ||
| S | N/A | N/A | 1957 | L6.2 | L6 | R | - | - | |||
| 1036 | Cameroon | L4 | R | - | - | 1102 | L6.2 | L6 | R | - | - |
| 1034 | Cameroon | L4 | R | - | - | 1434 | L6.3 | L6 | R | - | - |
| 1327 | Cameroon | L4 | R | - | - | 2150 | L6.3 | L6 | S | - | - |
| 1307 | Cameroon | L4 | R | - | - | 1289 | L6.3 | L6 | R | - | - |
| 1346 | Cameroon | L4 | R | - | - | 1421 | L5.1 | L5 | R | - | - |
| 1979 | Ghana | L4 | R | - | - | 2910 | L5.2 | L5 | R |
| A11D |
| 2070 | Ghana | L4 | R | - | - | 1010 | L5.2 | L5 | R |
| A11D |
| 1800 | Ghana | L4 | R | - | - | 1786 | L5.1 | L5 | R | - | - |
| 1608 | Ghana | L4 | R | - | - | 2541 | L5.3 | L5 | R | - | - |
| 1448 | Ghana | L4 | R | - | - | 2196 | L5.3 | L5 | R | - | - |
| 1280 | L6.1 | L6 | R | - | - | 2384 | L5.4 | L5 | R | - | - |
| 1821 | L6.1 | L6 | R | - | - | 1984 | L5.4 | L5 | R | - | - |
| 2016 | L6.1 | L6 | R | - | - | 1144 | L5.5 | L5 | R | - | - |
| 1082 | L6.2 | L6 | R | - | - | 1313 | L5.5 | L5 | R | - | - |